Melanoma antigen family A4 protein produced by transgenic silkworms induces antitumor immune responses

Recent clinical trials with the aim of developing tumor antigen (TA)-specific cancer vaccines against a number of malignancies have focused on the identification of TAs presented by tumor cells and recognized by T cells. In the present study, the TA melanoma antigen family A4 (MAGE-A4) protein was p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Ther Med
Autors principals: Motokawa, Yoko, Kokubo, Michifumi, Kuwabara, Nobuo, Tatematsu, Ken-Ichiro, Sezutsu, Hideki, Takahashi, Hideyuki, Sakakura, Koichi, Chikamatsu, Kazuaki, Takeda, Shigeki
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2018
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5854940/
https://ncbi.nlm.nih.gov/pubmed/29563979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.5703
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars